Newsfeeds - Spark Newswire

3 minute read

The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week

Today, 1:20 PM

Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference.

ALNY

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:20 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

4 minute read

Stocks Hitting New 52-Week Lows Today

By Benzinga Insights

Today, 1:20 PM

On Monday morning, 60 companies achieved new lows for the year.

AGIL

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 1:20 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALGN

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 1:20 PM

Gainers

ABSI

2 minute read

4 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 1:20 PM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BRST

2 minute read

18 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 1:20 PM

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.

ASRT

3 minute read

TYME Technologies, Inc. Announces TYME-19 ‘demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells’; Plans To Advance Toward IND For TYME-19

By Bill Haddad

Today, 1:20 PM

-- TYME-19 demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells, a model frequently used for drug screening for antiviral efficacy -- -- Completed toxicity studies with TYME-19 that are

TYME

1 minute read

Tyme Technologies Q3 EPS $(0.03) Up From $(0.05) YoY

By Luke J Jacobi

Today, 1:20 PM

Tyme Technologies (NASDAQ:TYME) reported quarterly losses of $(0.03) per share. This is a 40 percent increase over losses of $(0.05) per share from the same period last year.

TYME

12 minute read

Earnings Scheduled For November 8, 2021

By Benzinga Insights

Today, 1:20 PM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.

ACAD